| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.00084 | 1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.00079 | 1 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.0006 | 1 |